
|Articles|May 1, 2004
- Volume 0 0
Cream Restores Blood Flow to Feet
Advertisement
A recent study, the results of which were reported in Diabetes Care, found that Transdermal L-Arginine cream improved impaired blood flow in the feet of patients with diabetes. The cream enhanced circulation by 33% in the metatarsal region and by 35% at the Achilles tendon. Also, the cream increased temperature by 5?F at the metatarsal and by 8?F at the big toe.
L-Arginine is an amino acid that is the biochemical precursor of nitric oxide. Nitric oxide controls local blood flow by relaxing the smooth muscle lining of blood vessels.
Articles in this issue
over 22 years ago
Aging Brings Changesover 22 years ago
RxPRODUCT NEWS PROFILE: Cubicinover 22 years ago
Can You Read These Rxs?over 22 years ago
Treatment of Sexually Transmitted Diseasesover 22 years ago
Pharmacist Misappropriates Trade Secretsover 22 years ago
Topiramate May Reduce Frequency and Severity of Migraine Headachesover 22 years ago
HRT Is Linked to Breast Cancer Relapseover 22 years ago
Psoriasis May Be Treated Safely and Effectively with AdalimumabAdvertisement
Related to this article

Investigational antiamyloid monoclonal antibodies may offer a novel pathway to disease reversal.

A panel of cardiology pharmacists discussed the diagnostic red flags, evolving treatment landscape, and expanding pharmacist role central to identifying and managing ATTR-CM.

Weight-based norepinephrine dosing did not improve time to goal MAP, and median dose was similar compared with non–weight-based dosing in patients with septic shock.

The panelists emphasized that selecting a therapy is only one step toward improving outcomes for patients with heart failure.

Pharmacists can educate patients about staying up to date on immunizations and discuss fall prevention strategies.

Pharmacists describe their experiences using DEA certificates for controlled substance prescribing in different practice settings, as well as barriers and opportunities for future expansion.
Advertisement
Advertisement
Trending on Pharmacy Times
1
New Data Reshapes Nonstatin Lipid Therapy Choices
2
Eight Names, One Drug: Why Adalimumab Biosimilars Are Creating Real Confusion at the Counter
3
Etentamig Reduces Risk of Progression or Death by 60% in Relapsed/Refractory Multiple Myeloma
4
Community Pharmacy Must Pair Trust With Digital Convenience
5


